Location: FORT WORTH, TX
CIK: 0001536054 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $46.27M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS INC | 2,210,732 (-21.3%) | $42.45M (-8.5%) | 91.7% | $33.82 | -42.0% | COM | 24823R105 |
| SANA | SANA BIOTECHNOLOGY INC | 755,736 (-38.1%) | $2.177M (-56.2%) | 4.7% | $21.17 | -79.5% | COM | 799566104 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EGHT | 8X8 INC NEW | 990,850 | $1.645M | 3.6% | $4.02 | -48.8% | COM | 282914100 |